IP

Ian Peikon

Venture Partner at Lux Capital

Seattle, Washington

Overview

Work Experience

CN

Cajal Neuroscience

  • Co-Founder & Co-Chief Executive Officer

    2020 - Current

P

Plexium

  • Board Member

    2022

LC

Lux Capital

  • Venture Partner

    2019

VNV Bio

  • Co-Founder & SAB Member

    2018 - 2022

    non-viral gene therapy delivery systems - acquired by Aera Therapeutics

K

Kallyope

  • Co-Founder & Director, Platform Biology & Technology

    2015 - 2019

    I was part of the founding team of Kallyope and led the platform for new target discovery.

Education

Investments

Cajal Neuroscience

Seed

Total Funding: $96M

Relevant Websites